Fig. 2From: Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, RussiaGraph: Time to initiation of treatment with Second Line anti-TB drugs among patients with RIF-resistant TB. Note: SLD treatment regimens of 2 XDR-TB patients included in the graph were adjusted according to SLD DST resultsBack to article page